D5 Health - Personalized Longevity Clinic

D5 Health operates as a personalized longevity clinic in Raleigh, North Carolina, where Dr. Philip Deibel applies board certifications from the American Board of Lifestyle Medicine, American College of Obstetricians and Gynecologists, and American Academy of Anti-Aging Medicine to deliver hormone optimization and age-management protocols. The clinic structures treatment around advanced diagnostic testing that measures biomarkers beyond standard laboratory panels, establishing baseline metrics for hormonal status, metabolic function, and cellular health indicators that inform individualized intervention strategies. Dr. Deibel's dual background in obstetrics-gynecology and anti-aging medicine enables comprehensive hormone assessment for both men and women, addressing testosterone deficiency, estrogen-progesterone imbalances, thyroid dysfunction, and adrenal insufficiency through precision replacement protocols that restore physiologic levels rather than applying standardized dosing.

Peptide therapy at D5 Health includes targeted compounds selected based on diagnostic findings and patient-specific longevity goals, with protocols incorporating growth hormone secretagogues for body composition optimization, thymosin peptides for immune system support, and BPC-157 or TB-500 for tissue repair and recovery enhancement. The clinic integrates peptide treatments within broader hormone optimization programs that may include bioidentical testosterone, human chorionic gonadotropin for fertility preservation, and thyroid hormone replacement when indicated by laboratory values and clinical presentation. Treatment plans combine pharmaceutical-grade peptides with lifestyle medicine interventions that address nutrition quality, exercise programming, sleep architecture, and stress physiology—reflecting Dr. Deibel's certification in lifestyle medicine and the clinic's foundation in evidence-based longevity science rather than isolated symptom management.

Dr. Deibel conducts in-person consultations at the Raleigh clinic location, performing comprehensive intake assessments that review medical history, current symptoms, fitness objectives, and longevity priorities before ordering diagnostic panels. Initial evaluations typically include extended hormone testing, metabolic markers, inflammatory cytokines, and nutrient status measurements that create a quantified health profile. Follow-up protocols involve regular monitoring through repeat laboratory testing at intervals determined by treatment type, with dosage adjustments based on symptom resolution and biomarker optimization rather than fixed schedules. The clinic's approach emphasizes patient education regarding the physiologic mechanisms underlying hormone decline, peptide receptor activity, and the cellular processes targeted by longevity interventions, enabling informed participation in treatment decisions.

Patients at D5 Health receive structured protocols that specify peptide administration schedules, injection techniques for subcutaneous delivery, proper storage requirements, and expected timelines for clinical effects based on the compound's mechanism of action. The clinic provides ongoing access for questions regarding treatment response, side effect management, and protocol adjustments as patients progress through optimization phases. Supplement recommendations accompany peptide and hormone therapies when diagnostic testing reveals specific deficiencies or when evidence supports synergistic effects with primary treatments, though supplementation remains secondary to pharmaceutical interventions with established pharmacokinetics and clinical endpoints.

D5 Health distinguishes itself in the Raleigh longevity medicine landscape through Dr. Deibel's integration of reproductive endocrinology expertise with anti-aging protocols, creating particular value for patients seeking fertility preservation alongside performance optimization, women navigating perimenopause and menopause transitions, and individuals requiring sophisticated hormone balancing beyond testosterone-only approaches. The clinic's technology infrastructure supports detailed tracking of biomarker trends over time, allowing patients and providers to visualize treatment effects on objective health metrics rather than relying solely on subjective symptom reporting. This data-driven methodology aligns with the clinic's longevity focus, where interventions target measurable improvements in biological age markers, metabolic efficiency, body composition parameters, and cardiovascular risk factors that correlate with healthspan extension and age-related disease prevention.